Aktiesnakken — Juni 2010
-
-
-
genmab er totalt ustoppelig.
-
vildt at AU har så stor indflydelse i en C20 aktie
-
det må være short lukning noget af det
-
jeg tror jeg vil liste nogle af de forbudte ud...lidt profit kan man da ta
-
det er AktieUgebrevet der har landet en buy anbefaling med kursmål 123 og folk går amok
-
den skær simpelthen igennem alt
-
men husk nu at det var varnæs og jeg der kaldte bunden
-
AU har jo Danmarks største genmab ekspert ubetinget i Peter Aabo
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind